Enhancement of lymphokine-activated killer cell activity by fibronectin

Journal of Immunotherapy

Volumn 20, Issue 2, 1997, Pages 123-130

  Li, Yong Qing ^a   Kobayashi, Masanobu ^a   Kuramitsu, Yasuhiro ^a   Yuan, Lan ^a   Matsushita, Kazuhiro ^a   Yagita, Hideo ^b   Okumura, Ko ^b   Hosokawa, Masuo ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

^b JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Adhesion molecule; Extracellular matrix protein; Lymphokine activated killer (LAK) activity

Indexed keywords

FIBRONECTIN; MONOCLONAL ANTIBODY;

ANCHORAGE INDEPENDENT GROWTH; ANIMAL CELL; ANTIGEN EXPRESSION; ARTICLE; CELL ADHESION; CONJUGATION; EXTRACELLULAR MATRIX; IMMOBILIZED CELL; IMMUNOREGULATION; LYMPHOKINE ACTIVATED KILLER CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPLEEN CELL; TARGET CELL;

ANIMALS; ANTIBODIES, MONOCLONAL; CELL ADHESION; EXTRACELLULAR MATRIX PROTEINS; FEMALE; FIBRONECTINS; IMMUNOPHENOTYPING; KILLER CELLS, LYMPHOKINE-ACTIVATED; LYMPHOCYTE FUNCTION-ASSOCIATED ANTIGEN-1; MICE; MICE, INBRED C57BL; OLIGOPEPTIDES; RECEPTORS, FIBRONECTIN; SPLEEN;

EID: 0031464137     PISSN: 10538550     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Hynes RO. Integrins: versatility, modulation, and signalling in cell adhesion. Cell 1992;69:11-25.
2. Hemler ME. VLA proteins in the integrin family: structures, functions and their role on leukocytes. Ann Rev Immunol 1990;8:365-74.
3. Nojima Y, Humphries MJ, Mould AP, et al. VLA-4 mediates CD3-dependent CD4+ T cell activation via the CS-1 alternatively spliced domain of fibronectin. J Exp Med 1990; 172:1185-92.
4. Davis LS, Oppenheimer-Marks N, Bednarczyk JL, McIntyre BW, Lipsky PE. Fibronectin promotes proliferation of naive and memory T cells by signaling through both the VLA-4 and VLA-5 integrin molecules. J Immunol 1990;145:785-93.
5. Shimizu Y, Van seventer GA, Horgan KJ, Show S. Costimulation of proliferative responses of resting CD4+ T cells by the interaction of VLA-4 and VLA-5 with fibronectin or VLA-6 with laminin. J Immunol 1990;145:59-67.
6. Matsuyama T, Yamada A, Kay J, et al. Activation of CD44+ cells by fibronectin and anti-CD3 antibody: a synergistic effect mediated by the VLA-5 fibronectin receptor complex. J Exp Med 1989;170:1133-48.
7. Grimm EA, Mazumder A, Zhang HZ, Rosenberg SA. The lymphokine-activated killer cell phenomenon: lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes. J Exp Med 1982;155:1823-41.
8. Herberman RB, Hiseralt J, Vujanovic N. Lymphokine-activated killer cell activity: characteristics of effector cells and their progenitors in blood and spleen. Immunol Today 1987;8:178-84.
9. Mainiero F, Gismondi A, Milella M, et al. Long term activation of natural killer cells results in modulation of b1-integrin expression and function. J Immunol 1994;152:446-54.
10. Ishikawa M, Okada F, Hamada J, Hosokawa M, Kobayashi H. Changes in the tumorigenic and metastatic properties of tumor cells treated with quercetin or 5-azacytidine. Int J Cancer 1987;39:338-42.
11. Miyake S, Sakurai T, Okumura K, Yagita H. Identification of collagen and laminin receptor integrins on murine T lymphocytes. Eur J Immunol 1994;24:2000-5.
12. Yasuda M, Hasunuma Y, Adachi H, et al. Expression and function of fibronectin binding integrins on rat mast cells. Int Immunol 1995;7:251-8.
13. Miyake K, Weissman IL, Greenberger JS, Kincade PW. Evidence for a role of the integrin VLA-4 in lymphohemopoiesis. J Exp Med 1991;173:599-607.
14. Takahashi K, Nakamura Y, Koyanagi M, et al. A murine very late activation antigen-like extracellular matrix receptor involved in CD2- and lymphocyte function-associated antigen-1-independent killer-target cell interaction. J Immunol 1990;145:4371-9.
15. Perez P, Bluestone JA, Stephany DA, Segal DM. Quantitative measurements of the specificity and kinetics of conjugate formation between cloned cytotoxic T lymphocytes and splenic target cells by dual parameter flow cytometry. J Immunol 1985;134:478-85.
16. Rabinowich H, Lin WC, Amoscato A, Herberman RB, Whiteside TL. Expression of vitronectin receptor on human NK cells and its role in protein phosphorylation, cytokine production, and cell proliferation. J Immunol 1995;154:1124-35.
17. Young D, Liu CC, Rersechni PM, Cohn ZA. Perforin-dependent and -independent pathway of cytotoxicity mediated by lymphocytes. Immunol Rev 1988;103:161-82.
18. Watanabe-Fukunaga R, Brannan CI, Itoh N, et al. The cDNA structure, expression, and chromosomal assignment of the mouse Fas antigen. J Immunol 1992;148:1274-9.
19. Krensky AM, Robbins E, Springer TA, Burakoff SJ. LFA-1, LFA-2, and LFA-3 antigens are involved in CTL-target conjugation. J Immunol 1984;132:2180-2.
20. Nakamura T, Takahashi K, Fukuzawa T, et al. Relative contribution of CD2 and LFA-1 to murine T and natural killer cell functions. J Immunol 1990;145:3628-34.
21. Dustine ML, Springer TA. T-cell receptor cross-linking transiently stimulates adhesiveness through LFA-1. Nature 1989;341:619-24.
22. Medler RJ, Whiteside TL, Vujanovic NL, Herberman RB. A new approach to generating antitumor effectors for adoptive immunotherapy using human adherent lymphokine-activated killer cells. Cancer Res 1988;48:3461-9.